NSN 6505-01-610-9030, 6505016109030
Cancelled -> Replaced by 6505015055813

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 016109030
Codification Country: United States
Item Name Code: INC 09376
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Readily Available Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-610-9030

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-610-9030

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-610-9030

National Stock Number (NSN) 6505-01-610-9030, or NIIN 016109030, (morphine sulfate injection) was assigned August 29, 2012 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN replaces 1 stock number, 6505015055813.

There are 4 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 3 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 2 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over a year. There have been 9 contracts issued for this part number, with 34 awards given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPE2DP20P0477, SPE2DP20P0477, SPE2DP20P0477, SPE2DX15D9383, SPE2DX15D9383. The total value of the awarded contracts has been US$ 291,238.60.

This national stock number is in high demand. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Aug 31, 2012, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 09376. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505016109030 does not contain precious metals.

This information was last updated on Apr 01, 2024.

Technical Characteristics

MEDICAL DESIGNATION: (MDES) UNITED STATES PHARMACOPEIA
III PROTECTIVE STORAGE FEATURE: (AJCN) SECURITY STORAGE
III CONTROLLED SUBSTANCE CLASSIFICATION: (CRYC) SCHEDULE II
III PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) MORPHINE SULFATE INJECTION 10MG/ML 1ML 10S
ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 10.0 MILLIGRAMS MORPHINE SULFATE PER MILLILITER
CONTROLLED SUBSTANCE CLASSIFICATION: (CRYC) SCHEDULE II
MEDICAL DESIGNATION AND GRADE: (MDES) UNITED STATES PHARMACOPEIA
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) MORPHINE SULFATE INJECTION 10MG/ML 1ML 10S
PRIMARY CONTAINER CONTENT QUANTITY: (CRLK) 1.0 MILLILITERS
PROTECTIVE STORAGE FEATURE: (AJCN) SECURITY STORAGE
SPECIAL FEATURES: (FEAT) MORPHINE SULFATE INJECTION, USP; PRESERVATIVE FREE; 10 MG/ML; CARPUJECT SLIM PACK, 1 ML; PACKAGE OF 10; VAULT STORAGE; SCHEDULE II; FOR INTRAVENOUS USE ONLY.
TOTAL PRIMARY CONTAINER QUANTITY: (CSCW) 10